Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt

NCT05813496 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Polyneuropathy, Diabetic

Interventions

DRUG: Alpha-Lipoic Acid (ALA)
DRUG: Placebo

Sponsor

Eva Pharma

Collaborators

[object Object]